| Last Action | posting waived |
|---|---|
| Title | AN ACT relating to health insurance coverage of abuse-deterrent opioid analgesic drug products. |
| Bill Documents |
Bill
|
| Impact Statements | Health Mandate |
| Bill Request Number | 1523 |
| Sponsor | J. Greer |
| Summary of Original Version | Create a new section of Subtitle 17A of KRS Chapter 304 to define "abuse-deterrent opioid analgesic drug product," and "cost sharing," and "opioid analgesic drug product" ; require an insurer or health benefit plan to provide coverage for abuse-deterrent opioid analgesic drug products as preferred drugs on its formulary or similar lists of coverage of prescriptions; prohibit exceeding the lowest cost-sharing level applied to prescription drugs in the same health benefit plan; prohibit disincentives for prescribers or dispenser for abuse-deterrent opioid analgesic drug products; provide that a person who has received or been denied an opioid analgesic drug product by an insurer shall not be first required to use a non-abuse deterrent opioid analgesic drug product before accessing an abuse-deterrent opioid analgesic drug product. |
| Index Headings of Original Version |
Drugs and Medicines - Opioid analgesic drug products, health benefit plan coverage requirements Insurance - Health benefit plan coverage, opioid and abuse-deterrent analgesic drug products, requirements Insurance, Health - Opioid analgesic and abuse-deterrent analgesic drug products, requirements Health Benefit Mandate - Health benefit plan coverage, opioid and abuse-deterrent analgesic drug products, requirements |
| 02/23/15 |
|
|---|---|
| 02/24/15 |
|
Last updated: 1/16/2019 3:10 PM (EST)